FINWIRES · TerminalLIVE
FINWIRES

Research Alert: CFRA Keeps Buy Opinion On Shares Of Aecom

By

CFRA, an independent research provider, has providedwith the following research alert. Analysts at CFRA have summarized their opinion as follows:

We lower our 12-month target by $29 to $96, 15.5x our next-12-month EPS estimate of $6.20, below ACM's five-year historical forward average of 20.5x. We lift our FY 26 EPS view by $0.05 to $6.04 and lower our FY 27 EPS view by $0.11 to $6.75. While near-term revenue growth remains modest and policy volatility warrants monitoring, we believe the risk/reward profile is favorable at current valuation levels given AECOM's operational momentum and pathway to industry-leading profitability. The company's raised guidance, accelerated capital returns, and demonstrated ability to navigate policy disruptions support our constructive view. While the Middle East conflict has created near-term revenue impacts, the region continues to generate strong backlog additions. We think international diversification provides additional growth avenues with strengthening momentum despite near-term headwinds. We expect total revenue growth of 1.7% in FY 26 and 6.1% in FY 27.

Related Articles

Research

HC Wainwright Downgrades Lisata Therapeutics to Neutral From Buy

Price: $3.18, Change: $+0.10, Percent Change: +3.28%

$LSTA
Research

Research Alert: CFRA Reiterates Buy Opinion On Shares Of Franco-nevada Corporation

CFRA, an independent research provider, has providedwith the following research alert. Analysts at CFRA have summarized their opinion as follows:We cut our 12-month target price by CAD27 to CAD416, as we now assume a lower P/E multiple (tracking the multiple contraction in the peer group). We now use a P/E of 28.0x (vs. 34.8x previously) applied to our 2027 EPS estimate. Our assumed P/E is in between FNV's two-year average forward P/E of 33.9x and peers' average forward P/E of 22.3x. The lower P/E multiple is partly offset by higher EPS estimates mostly due to higher commodity prices: we increased 2026's to USD9.57 (from USD8.61) and 2027's to USD10.81 (from USD9.30). FNV's royalty/streaming model provides significant operating leverage to commodity prices while remaining largely insulated from cost inflationa key differentiator in the current environment. The company boasts the sector's largest and most diversified portfolio of 121 cash-flow producing assets, with resources supporting 34 years of mine life at current production rates. With USD3.4B in available capital and a robust acquisition pipeline, FNV is well-positioned for continued growth.

$FNV
Research

Update: Morgan Stanley Downgrades Viking Holdings to Equalweight From Overweight on More Balanced Risk-reward, Raises Price Target to $86 From $81

(Updates with Morgan Stanley's commentary.)Morgan Stanley, in a note Friday, downgraded Viking (VIK) to equalweight from overweight saying their original bull thesis has already been reflected in the stock price, "leaving a more balanced risk reward and fairly valued stock."Analysts at the brokerage also raised the company's price target to $86 from $81 alongwith its '27/'28 EBITDA estimates, citing stronger 2027 booking demand."We still expect positive revisions from here as 11% pricing for 2027 should set the stage for yields well above consensus at ~4.5% (we are at ~6%)", the note said.Viking has an average rating of overweight and mean price target of $92, according to analysts polled by FactSet.(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://www..com/contact-us)Price: $83.64, Change: $-3.08, Percent Change: -3.55%

$VIK